What advances coming in 2018 have the most potential to affect the care of our patients with advanced NSCLC? H. Jack West, MD, offers his thoughts.
What is the best approach for our patients with progressive ALK-positive NSCLC? Here I share my thoughts based on the latest available evidence on using ALK inhibitors in the setting of progressive disease.
How will the new dosing schedule for nivolumab in NSCLC affect our current practice? Here are my thoughts.
The optimal treatment of newly diagnosed patients with advanced NSCLC is changing. Here is how new findings reported at AACR 2018 are affecting my clinical practice.
Leora Horn, MD, MSc, FRCPC, provides insight on the optimal treatment of patients with advanced NSCLC and both an oncogenic driver mutation and high PD-L1 tumor expression.
Leora Horn, MD, MSc, FRCPC, provides insight on the optimal management of patients with progressive advanced squamous NSCLC with unknown PD-L1 expression.
Download this simple resource providing an overall summary of advanced NSCLC care including an up-to-date treatment algorithm, toxicity management, and a listing of key enrolling clinical trials.
In this Virtual Presentation, Melissa L. Johnson, MD, discusses current expert treatment recommendations for 3 key patient scenarios in the rapidly evolving therapeutic landscape of advanced NSCLC. Afterwards, download the slides and use the treatment decision tool for your practice.
In this downloadable slideset, Melissa L. Johnson, MD, presents recent practice changing data that impacts the management of patients with advanced NSCLC. Click here to use our online tool to see how to select optimal therapy for your patients.
Use this Interactive Decision Support Tool to get treatment recommendations from David R. Gandara, MD; Melissa L. Johnson, MD; Suresh S. Ramalingam, MD; Heather Wakelee, MD; and H. Jack West, MD, for your patients with advanced NSCLC.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.